Teva, Baxter Told To Pay $104M In Propofol Hepatitis Case

Law360, New York (October 12, 2011, 7:41 PM EDT) -- A Nevada jury this week awarded $104 million in damages to a colonoscopy patient who sued U.S. subsidiaries of Teva Pharmaceutical Industries Ltd. and Baxter International Inc. claiming he contracted hepatitis from a reusable vial of the anesthetic Propofol.

The jury ordered punitive damages in the amount of $90 million Wednesday after ruling Monday that the companies should pay Michael Washington and his wife Josephine $14 million in compensation. The awards are the result of the third verdict against the defendants in a slew of suits...
To view the full article, register now.